Perspective Therapeutics Inc
ISR
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-19,522,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.4 |
| Beta | 0 |
| Outstanding Shares | 112,174,000 |
Return
| Return on Equity | -35.95% |
|---|---|
| Return on Assets | -29.70% |
| Return on Invested Capital | 2.51% |
Valuation & Multiples
| P/E Ratio | -2.31 |
|---|---|
| PEG | -9.35 |
| Price to Sales | -0.38 |
| Price to Book Ratio | 0.19 |
| Enterprise Value to Revenue | 256.87 |
| Enterprise Value to EBIT | -2.19 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -1.48 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 83,300▲ 535.88% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 49.24%▼ 8.00% |
|---|---|
| Total Invested | $14.05M▼ 13.97% |
| Investors Holding | 118▲ 14.00% |
ESG Score
No data
About Isoray, Inc.
CEO: Dwight Babcock